- Home
- DCTH vs RWAY Comparison
DCTH vs RWAY Comparison
Compare DCTH & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- RWAY
- Stock Information
- Founded
- DCTH 1988
- RWAY 2015
- Country
- DCTH United States
- RWAY United States
- Employees
- DCTH 76
- RWAY N/A
- Industry
- DCTH Medical/Dental Instruments
- RWAY
- Sector
- DCTH Health Care
- RWAY
- Exchange
- DCTH Nasdaq
- RWAY Nasdaq
- Market Cap
- DCTH 426.3M
- RWAY 395.5M
- IPO Year
- DCTH N/A
- RWAY 2021
- Fundamental
- Price
- DCTH $11.52
- RWAY $10.95
- Analyst Decision
- DCTH Strong Buy
- RWAY Buy
- Analyst Count
- DCTH 4
- RWAY 5
- Target Price
- DCTH $24.00
- RWAY $10.50
- AVG Volume (30 Days)
- DCTH 873.0K
- RWAY 313.0K
- Earning Date
- DCTH 08-04-2025
- RWAY 08-07-2025
- Dividend Yield
- DCTH N/A
- RWAY 12.97%
- EPS Growth
- DCTH N/A
- RWAY 51.80
- EPS
- DCTH N/A
- RWAY 1.67
- Revenue
- DCTH $53,850,000.00
- RWAY $140,021,000.00
- Revenue This Year
- DCTH $155.42
- RWAY N/A
- Revenue Next Year
- DCTH $37.93
- RWAY N/A
- P/E Ratio
- DCTH N/A
- RWAY $6.61
- Revenue Growth
- DCTH 1068.87
- RWAY N/A
- 52 Week Low
- DCTH $7.17
- RWAY $8.35
- 52 Week High
- DCTH $18.23
- RWAY $12.09
- Technical
- Relative Strength Index (RSI)
- DCTH 32.83
- RWAY 65.15
- Support Level
- DCTH $12.11
- RWAY $10.74
- Resistance Level
- DCTH $14.15
- RWAY $11.05
- Average True Range (ATR)
- DCTH 0.57
- RWAY 0.20
- MACD
- DCTH -0.16
- RWAY 0.02
- Stochastic Oscillator
- DCTH 9.67
- RWAY 81.32
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.